EDIT vs. PACB
Compare and contrast key facts about Editas Medicine, Inc. (EDIT) and Pacific Biosciences of California, Inc. (PACB).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EDIT or PACB.
Key characteristics
| EDIT | PACB | |
|---|---|---|
| YTD Return | -62.88% | -81.24% |
| 1Y Return | -40.22% | -75.10% |
| 3Y Return (Ann) | -53.86% | -58.55% |
| 5Y Return (Ann) | -29.07% | -19.03% |
| Sharpe Ratio | -0.56 | -0.65 |
| Sortino Ratio | -0.58 | -0.80 |
| Omega Ratio | 0.94 | 0.90 |
| Calmar Ratio | -0.43 | -0.77 |
| Martin Ratio | -0.92 | -1.14 |
| Ulcer Index | 45.13% | 66.01% |
| Daily Std Dev | 73.78% | 116.20% |
| Max Drawdown | -96.73% | -97.65% |
| Current Drawdown | -95.85% | -96.40% |
Fundamentals
| EDIT | PACB | |
|---|---|---|
| Market Cap | $277.12M | $501.45M |
| EPS | -$2.33 | -$1.50 |
| PEG Ratio | 0.00 | -0.17 |
| Total Revenue (TTM) | $61.70M | $133.18M |
| Gross Profit (TTM) | $57.40M | $19.12M |
| EBITDA (TTM) | -$158.56M | -$206.13M |
Correlation
The correlation between EDIT and PACB is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
EDIT vs. PACB - Performance Comparison
In the year-to-date period, EDIT achieves a -62.88% return, which is significantly higher than PACB's -81.24% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EDIT vs. PACB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Editas Medicine, Inc. (EDIT) and Pacific Biosciences of California, Inc. (PACB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
EDIT vs. PACB - Dividend Comparison
Neither EDIT nor PACB has paid dividends to shareholders.
Drawdowns
EDIT vs. PACB - Drawdown Comparison
The maximum EDIT drawdown since its inception was -96.73%, roughly equal to the maximum PACB drawdown of -97.65%. Use the drawdown chart below to compare losses from any high point for EDIT and PACB. For additional features, visit the drawdowns tool.
Volatility
EDIT vs. PACB - Volatility Comparison
The current volatility for Editas Medicine, Inc. (EDIT) is 20.08%, while Pacific Biosciences of California, Inc. (PACB) has a volatility of 32.97%. This indicates that EDIT experiences smaller price fluctuations and is considered to be less risky than PACB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
EDIT vs. PACB - Financials Comparison
This section allows you to compare key financial metrics between Editas Medicine, Inc. and Pacific Biosciences of California, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities